Ottawa-based life sciences startup lands US$11.5M in fresh equity to fund cutting-edge cancer drugs
Orion Biotechnology is working on treatments that use the body’s immune system to target cancer, HIV, COVID-19 and other diseases.
Ottawa-based life sciences startup lands US$11.5M in fresh equity to fund cutting-edge cancer drugs
Orion Biotechnology is working on treatments that use the body’s immune system to target cancer, HIV, COVID-19 and other diseases.
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored
Understanding search and seizure laws
Expanding Your business in the USA today?
The private sector has a role to play in reconciliation
Equity, Diversity and Inclusion: Return of the Pendulum